Using "rationally designed drugs" rationally.
Brugarolas
Jim
J
Dana Farber Cancer Institute, Boston, MA 02115, USA. james_brugarolas@dfci.harvard.edu <james_brugarolas@dfci.harvard.edu>
Clark
Jeffrey W
JW
Chabner
Bruce
B
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002986:Clinical Trials as Topic / Q000379:methods; D015195:Drug Design; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000145:classification / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D018579:Patient Selection; D015203:Reproducibility of Results; D012107:Research Design
D000970:Antineoplastic Agents